Trademark: 97477233
Status Date
Thursday, March 14, 2024
Filing Date
Monday, June 27, 2022
Published for Opposition
Tuesday, August 1, 2023
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations, namely, oral and injectable contraceptives and hormone replacement therapy preparations, specifically, women's hormone replacement medications
Mar 15, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 14, 2024
Sou Extension 1 Granted
Mar 14, 2024
Sou Extension 1 Filed
Mar 14, 2024
Sou Teas Extension Received
Sep 26, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 1, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 1, 2023
Published For Opposition
Jul 12, 2023
Notification Of Notice Of Publication E-Mailed
Jun 23, 2023
Approved For Pub - Principal Register
Jun 16, 2023
Teas/Email Correspondence Entered
Jun 15, 2023
Correspondence Received In Law Office
Jun 15, 2023
Teas Response To Office Action Received
Apr 19, 2023
Notification Of Non-Final Action E-Mailed
Apr 19, 2023
Non-Final Action E-Mailed
Apr 19, 2023
Non-Final Action Written
Apr 11, 2023
Assigned To Examiner
Feb 22, 2023
Teas Change Of Correspondence Received
Feb 22, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 22, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 22, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 14, 2022
New Application Office Supplied Data Entered
Jun 30, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24